Biotech & pharma
Solution to 50-year-old mystery could lead to gene therapy for common blood disorders
03 Apr 2018
The research solves a 50-year-old mystery about how these mutations, which are naturally carried by a small percentage of people, operate and alter the expression of human genes
New innovations in cell-free biotechnology
26 Mar 2018
Cancer comes back all jacked up on stem cells
21 Mar 2018
Nanostructures could make gene therapies
15 Mar 2018
Saving lives with platypus milk
15 Mar 2018
Molecule that gives energy-burning brown fat its identity could lead to drugs for obesity
14 Mar 2018
Engineers create most efficient red light-activated optogenetic switch for mammalian cells
14 Mar 2018
Long stay in space could alter DNA, NASA’s Kelly twins study shows
10 Mar 2018
After landing, 93 per cent of Scott Kelly’s genes returned to normal, the researchers found. The altered 7 per cent, however, could indicate long-term changes in genes connected to the immune system,
Culturing cheaper stem cells
07 Mar 2018
Metabolic modelling becomes three-dimensional
27 Feb 2018
Latest articles
Featured articles
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.


